• OPEN AN ACCOUNT
Indian Indices
Sensex
78,918.90 -1,097.00
( -1.37%)
Global Indices
Nasdaq
47,518.20 -457.55
(-0.95%)
Dow Jones
6,761.35 -90.36
(-1.32%)
Hang Seng
55,600.46 322.40
(0.58%)
Nikkei 225
10,286.75 -127.19
(-1.22%)
Forex
USD-INR
91.74 -0.39
(-0.42%)
EUR-INR
106.47 -0.59
(-0.55%)
GBP-INR
122.42 -0.61
(-0.50%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
535469
INE0LA901015
12.7840006
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JFLLIFE
7.71
37.12
EPS(TTM)
Face Value()
Div & Yield %
1.46
10
0
 

ABB India consolidated net profit declines 18.08% in the December 2025 quarter
Feb 20,2026
Net profit of ABB India declined 18.08% to Rs 432.85 crore in the quarter ended December 2025 as against Rs 528.41 crore during the previous quarter ended December 2024. Sales rose 5.08% to Rs 3495.79 crore in the quarter ended December 2025 as against Rs 3326.88 crore during the previous quarter ended December 2024.

For the full year,net profit declined 10.87% to Rs 1668.26 crore in the year ended December 2025 as against Rs 1871.64 crore during the previous year ended December 2024. Sales rose 8.09% to Rs 13065.32 crore in the year ended December 2025 as against Rs 12087.67 crore during the previous year ended December 2024.

ParticularsQuarter EndedYear Ended
Dec. 2025Dec. 2024% Var.Dec. 2025Dec. 2024% Var.
Sales3495.793326.88 5 13065.3212087.67 8
OPM %15.6319.76 -15.6419.07 -
PBDT617.23738.83 -16 2375.472642.18 -10
PBT577.59705.13 -18 2229.942513.26 -11
NP432.85528.41 -18 1668.261871.64 -11